JODI STROCK: Open Payments
NPI 1417236530 · AUBURN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,137 in 129 payments from 22 companies in 2025. Trend: 2023 $3,931 · 2024 $3,731 · 2025 $3,137
Food & beverage: $3,137
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $501 |
| Novo Nordisk Inc | 11 | $384 |
| ABBVIE INC. | 30 | $383 |
| Axsome Therapeutics, Inc. | 16 | $369 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $299 |
| PFIZER INC. | 6 | $212 |
| Amgen Inc. | 8 | $211 |
| Lilly USA, LLC | 9 | $185 |
| Otsuka America Pharmaceutical, Inc. | 5 | $176 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
Products named: Auvelity, CAPLYTA, NURTEC ODT, BREZTRI, REXULTI, Ozempic, FARXIGA, Wegovy.
Industry payments across IN — which companies pay providers there.
